Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia

Clinical trial NCT05171751 · COMPLETED

Trial details

NCT number: NCT05171751
Sponsor: Beijing Children's Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Hyperinsulinaemic Hypoglycaemia Octreotide Adverse Reaction

Start date: 2021-11-01
Primary completion: 2021-12-18
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.